Tessera Therapeutics

Provider of new genome engineering technology for treating multiple diseases

placeCambridge, Massachusetts, United States calendar_todayFounded 2017 groups203 employees language tesseratherapeutics.com

Registered entities

Social engagement

Social engagement: 45.7K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

24 investors on record; lead investors include Altitude Life Science Ventures, Alaska Permanent Fund, SoftBank Vision Fund, ADIA.

Investor typeCountShare
Venture capital1458%
Private equity521%
Other / undisclosed521%
Coming soon